News
Nanogen Wins CDC Contract to Develop Avian Flu Diagnostic
SAN DIEGO (Dec. 4, 2006) – Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today it has been awarded a $4.5 million contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a unique multi-analyte Point-Of-Care (POC) diagnostic assay for Influenza in support of the US Government’s efforts to strengthen its readiness for a potential influenza pandemic.
Full story here.
Kleiner Perkins Caufield & Byers Forms $200 Million
Pandemic and Bio Defense Fund
MENLO PARK, CA., February 16, 2006 – Kleiner Perkins Caufield & Byers (KPCB) – a leader in providing relationship and venture capital SM services to entrepreneurs – announced the formation of a new fund, the KPCB Pandemic and Bio Defense Fund.
Full story here.
http://www.pandemicflu.gov/
Key Facts About Avian Influenza (Bird Flu) and Avian Influenza A (H5N1) Virus. Here.
Upcoming Events
2008 AACC Annual Meeting & Clinical Expo
2008 AMP Annual Meeting & Exhibits
For more, go to our News and Events page.
HX Diagnostics
HX Diagnostics, Inc. is a San Francisco bay area diagnostics company with a mission to be a global leader in rapid diagnostics for seasonal and emerging infectious diseases.
 
To find out about infectious disease around the world, click on the location below.